These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 34997835)

  • 1. Comparative Pharmacokinetics Between a Fixed-Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects.
    Na JY; Yang E; Kim JH; Kwon IS; Jin EH; Yu KS; Kim J; Lee S; Hong JH
    Clin Pharmacol Drug Dev; 2022 May; 11(5):615-622. PubMed ID: 34997835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects.
    Yang E; Lee S; Lee H; Hwang I; Jang IJ; Yu KS; Lee S
    Transl Clin Pharmacol; 2019 Dec; 27(4):134-140. PubMed ID: 32095481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction between pitavastatin and valsartan: a randomized, open-labeled crossover study in healthy male Korean volunteers.
    Jung JA; Noh YH; Jin S; Kim MJ; Kim YH; Jung JA; Lim HS; Bae KS
    Clin Ther; 2012 Apr; 34(4):958-65. PubMed ID: 22410289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study.
    Kim S; Ko JW; Kim JR
    Clin Pharmacol Drug Dev; 2020 Apr; 9(3):386-394. PubMed ID: 31373174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets.
    Hwang JG; Yu KS; Lee S
    Drug Des Devel Ther; 2020; 14():1953-1961. PubMed ID: 32546962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers.
    Yoon DY; Park SI; Jung JA; Kim YI; Jang IJ; Chung JY
    Drug Des Devel Ther; 2020; 14():661-668. PubMed ID: 32109991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
    Hedaya MA; Helmy SA
    Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects.
    Jung J; Lee S; Oh J; Lee S; Jang IJ; Lee D; Yu KS
    Transl Clin Pharmacol; 2021 Mar; 29(1):53-64. PubMed ID: 33855001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes.
    Lingvay I; Beetz N; Sennewald R; Schuler-Metz A; Bertulis J; Loley C; Lang B; Lippert C; Lee J; Manning LS; Terada D
    Postgrad Med; 2020 May; 132(4):337-345. PubMed ID: 32366156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
    Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
    Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers.
    Seong SJ; Ohk B; Kang WY; Gwon MR; Kim BK; Cho S; Yang DH; Lee HW; Yoon YR
    Adv Ther; 2019 Jul; 36(7):1642-1656. PubMed ID: 31119689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men.
    Choi HK; Ghim JL; Shon J; Choi YK; Jung JA
    Drug Des Devel Ther; 2016; 10():3493-3499. PubMed ID: 27822013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects.
    Khwarg J; Lee S; Jang IJ; Kang WH; Lee HJ; Kim KY; Jeong KS; Won C; Choi YW; Ha DC; Jung R; Han MG; Jung WT; Nam KY; Kim Y; Yu KS; Oh J
    Drug Des Devel Ther; 2024; 18():395-406. PubMed ID: 38352172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial in healthy subjects to assess the bioequivalence of an atazanavir/cobicistat fixed-dose combination tablet versus administration as separate agents.
    Sevinsky H; Tao X; Wang R; Ravindran P; Sims K; Xu X; Jariwala N; Bertz R
    Antivir Ther; 2015; 20(5):493-500. PubMed ID: 25361436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study.
    Migoya EM; Miller JL; Gutierrez M; Zheng W; Johnson-Levonas AO; Liu Q; Matthews CZ; Wagner JA; Gottesdiener KM
    Clin Drug Investig; 2010; 30(12):855-66. PubMed ID: 20923244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study.
    Yang E; Yoo H; Jang IJ; Yu KS; Lee S
    Drug Des Devel Ther; 2021; 15():651-658. PubMed ID: 33628012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.
    Choi Y; Lee S; Cho SM; Kang WH; Nam KY; Jang IJ; Yu KS
    Drug Des Devel Ther; 2016; 10():3021-3028. PubMed ID: 27703330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions.
    Wu L; Xu C; Wu G; Zhou H; Lv D; Zhai Y; Huang Y; Tang W; Li F; Shentu J
    Drug Des Devel Ther; 2019; 13():3331-3342. PubMed ID: 31571834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects.
    Hu C; Hu X; Wang C; Zhao Z; Gao D; Chen X; Zhou D; Huang Y; Li L; Zhang L
    Clin Drug Investig; 2018 Dec; 38(12):1145-1154. PubMed ID: 30232699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.